Pomalyst (Pomalidomide) Received a New Indication for Patients with Relapsed and/or Refractory Multiple Myeloma.

about

Pomalyst (Pomalidomide) Received a New Indication for Patients with Relapsed and/or Refractory Multiple Myeloma.

Item

http://www.wikidata.org/entity/Q37237715

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pomalyst (Pomalidomide) Receiv ...... r Refractory Multiple Myeloma.

@en

Pomalyst

@nl

type

Item

label

Pomalyst (Pomalidomide) Receiv ...... r Refractory Multiple Myeloma.

@en

Pomalyst

@nl

prefLabel

Pomalyst (Pomalidomide) Receiv ...... r Refractory Multiple Myeloma.

@en

Pomalyst

@nl

P1476

Pomalyst (Pomalidomide) Receiv ...... r Refractory Multiple Myeloma.

@en

P2093

Lisa A Raedler

http://www.w3.org/2001/XMLSchema#string

P2860

Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.

New strategies in the treatment of multiple myeloma.

Novel approaches to treatment of double-refractory multiple myeloma.

Health care costs and resource utilization, including patient burden, associated with novel-agent-based treatment versus other therapies for multiple myeloma: findings using real-world claims data.

Improved survival in multiple myeloma and the impact of novel therapies.

The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide mai

Multiple myeloma: the bone marrow microenvironment and its relation to treatment.

P304

111-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

Spec Feature

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27668057

http://www.w3.org/2001/XMLSchema#string

P932

5013859

http://www.w3.org/2001/XMLSchema#string